Leukaemia, malignancies and other late effects following administration of Thorotrast.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000139:chemically induced; D001859:Bone Neoplasms / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006390:Hemangioendothelioma / Q000139:chemically induced*; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D008113:Liver Neoplasms / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced; D013911:Thorium Dioxide / Q000009:adverse effects*; D013997:Time Factors
D013911:Thorium Dioxide